Biological
Ptvg-hp clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ptvg-hp is read from its arms, and is right about nine times in ten.
Testing it · 4
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerActive, not recruitingPhase 2University of Wisconsin, MadisonNCT03600350Written as pTVG-HP
- Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate CancerCompletedPhase 2University of Wisconsin, MadisonNCT01341652Written as pTVG-HP
- Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate CancerCompletedPhase 2University of Wisconsin, MadisonNCT00849121Written as pTVG-HP with rhGM-CSF
- Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate CancerCompletedPhase 1University of Wisconsin, MadisonNCT00582140Written as pTVG-HP with rhGM-CSF